A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/20/2006	CN1290502C Compositions for treatment of common cold
12/20/2006	CN1290501C Pharmaceutically active isoindoline derivatives
12/20/2006	CN1290500C Retroviral protease inhibitor combinations
12/20/2006	CN1290499C Usage of glanthidine, total alkali extract and preparation method and usage thereof
12/20/2006	CN1290498C Medicine for treating tinea pedis, and preparation method thereof
12/20/2006	CN1290497C Antiviral drug containing silverweed cinquefoil essence and its preparation method
12/20/2006	CN1290496C Clenbuterol hydrochloride plaster
12/20/2006	CN1290495C Lipid microspherical asarol preparation and its preparation process
12/20/2006	CN1290494C Externally applied long-acting analgesic
12/20/2006	CN1290493C Local therapy for skin virus infection
12/20/2006	CN1290492C Beta-elemene aerosol and its preparing method
12/20/2006	CN1290491C Medicine for treating acute ischemic cerebral apoplexy and its preparing method
12/20/2006	CN1290487C Traditional Chinese medicine foot bath agent for cleaning and healthcare
12/19/2006	USRE39433 Therapeutic agents as cytokine antagonists and agonists
12/19/2006	US7151196 Estrogen receptor modulators
12/19/2006	US7151191 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery
12/19/2006	US7151183 Processes for preparing amorphous atorvastatin hemi-calcium
12/19/2006	US7151178 Reacting 5-methylpyrazinecarboxylic acid with a C1-4 alcohol in acidic cation exchange resin to form the ester, then oxidizing with the potassium monopersulfate in the form of a triple salt 2KHSO5.KHSO4.K2SO4 in a halogenated solvent
12/19/2006	US7151176 5-[(4-aminopiperidin-1-yl)methyl]-N-[(1R)-1-phenylethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine for example; antiproliferative agents; inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	US7151172 virion infectivity factor (vif) proteins; use in vaccine against the HIV-1 virus
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151117 Administering a X-ray contrast media selected from iotrolan and iodixannol to an eye of a mammal suffering from allergic conjunctivitis and allergic rhinitis to decrease in histamine release; side effect reduction
12/19/2006	US7151116 Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells
12/19/2006	US7151115 Diphenylmethyl compounds useful as muscarinic receptor antagonists
12/19/2006	US7151114 Treatment or prevention of diseases involving glucagon receptors; antagonists which block the glucagon receptor is used for treating diabetes; inhibits the production of glucose in the liver; drugs with other active substance
12/19/2006	US7151113 Pyrazole-amine compounds useful as kinase inhibitors
12/19/2006	US7151112 TREATING A SUBJECT HAVING AN INFLAMMATORY DISORDER ALLEVIATED BY THE INHIBITION OF GRO- ALPHA CYTOKINES, or chemotaxis, with [5-(4-fluorophenylcarbamoyl)pyridin-2-yloxy]acetic acid butyl ester
12/19/2006	US7151111 Amine oxidase inhibitor; Alzheimer's disease
12/19/2006	US7151110 4-Methoxy-6-[3-(6-methyl-pyridin-2-yl)-1H-pyrazol-4-yl]-quinoline; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents
12/19/2006	US7151109 Psychological disorders; anxiolytic agents; antidepressants
12/19/2006	US7151108 Anticarcinogenic, antiproliferative, and antitumor agents
12/19/2006	US7151107 A quaternary ammonium salts of 1-{2-(3'-chlorobiphenyl-4-yl)-2-oxoethyl}-4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyridine; used as neuroprotectants, for prophylaxis of brain and nervous system disorders, Alzheimer's disease, senile dementia
12/19/2006	US7151106 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
12/19/2006	US7151105 Inhibitors of Hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/19/2006	US7151103 A serotonin receptor antagonists for therapeutic treatment
12/19/2006	US7151102 Phthalazinone derivatives
12/19/2006	US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases
12/19/2006	US7151100 Indole compounds useful for the treatment of cancer
12/19/2006	US7151099 Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases
12/19/2006	US7151098 Glutamate receptor antagonists
12/19/2006	US7151097 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
12/19/2006	US7151096 For therapy and prophylaxis of diseases and disorders associated with cyclin-dependent kinases (CDKs) activity
12/19/2006	US7151095 Oral and rectal drug delivery of a mixture of 4-aminophenylacetic acid and 5-aminosalicylic acid; antiinflammatory agents for gastrointestinal tract; antiulcer agents; bis(sodium carboxyl phenyl)azo compounds
12/19/2006	US7151094 For reduction of mucositis induced by radiation therapy; anticancer agents; side effect reduction
12/19/2006	US7151093 Use of sphingosine 1-phosphate as active ingredient for the treatment of pulmonary fibrosis
12/19/2006	US7151092 Cytarabine monophosphate prodrugs
12/19/2006	US7151091 preventing maternal to fetal transmission of a microorganism by administering a cholesterol-sequestering agent such as a cyclodextrin to the birth canal prior to vaginal birth of the fetus; also blood products for treating blood disorders; prevent transmission of viruses such as HIV to baby for example
12/19/2006	US7151090 Methods for enhancing graft survival by modulating heme oxygenase activity
12/19/2006	US7151089 7-(2'-C-methyl- beta -D-ribofuranosyl)-4-amino-5-(diisopropoxymethyl)-pyrrolo[2,3-d]pyrimidine; treating hepatitis C
12/19/2006	US7150883 Liposome suspension forms spontaneously upon adding a diacylglycerol-PEG lipid to an aqueous solution when the lipid has appropriate packing parameters and the adding occurs above the melting temperature of the lipid
12/19/2006	US7150880 Drink for athletes; creatine plays a pivotal role in the regulation and homeostasis of skeletal muscle energy metabolism
12/19/2006	US7150871 Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
12/19/2006	US7150869 Gene therapy; cytokine complex; anticancer agent
12/19/2006	US7150766 Method of particle formation
12/19/2006	CA2372238C Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
12/19/2006	CA2358062C Controlled release galantamine composition
12/19/2006	CA2356020C Cannabinoid patch and method for cannabis transdermal delivery
12/19/2006	CA2320087C Treatment of chronic inflammatory disorders of the gastrointestinal tract
12/19/2006	CA2301872C 8a-azalides as veterinary antimicrobial agents
12/19/2006	CA2301685C Sustained release drug delivery devices
12/19/2006	CA2297439C Carbostyril derivatives
12/19/2006	CA2296560C Amino acid derivatives useful to treat stroke
12/19/2006	CA2267973C Hydrophilic microparticles and methods to prepare same
12/19/2006	CA2264979C Dicyclic-aromatic compounds and their application in human and veterinary medicine, as well as in cosmetics
12/19/2006	CA2259538C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
12/19/2006	CA2251623C Buccal delivery system
12/19/2006	CA2251169C Quaternary cytofectins
12/19/2006	CA2246236C Treatment and prevention of adverse effects of reactive oxygen species
12/19/2006	CA2234957C Insoluble drug delivery
12/19/2006	CA2232880C Semi-fluorinated alkanes and their use
12/19/2006	CA2214448C Cereal food product high in soluble fiber
12/19/2006	CA2212537C Therapeutic inhibitor of vascular smooth muscle cells
12/19/2006	CA2202904C Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases
12/19/2006	CA2200966C Pharmaceutical compositions
12/19/2006	CA2194761C Immunomodulatory oligonucleotides
12/19/2006	CA2190778C Transmucosal delivery system
12/19/2006	CA2188297C Lactone stable formulation of camptothecin or 7-ethyl camptothecin
12/19/2006	CA2168659C Substituted azaindolylidene compounds and process for their preparation
12/19/2006	CA2162208C Percutaneous absorption preparation
12/19/2006	CA2159091C Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses
12/19/2006	CA2158863C Taxanes having a pyridyl substituted side-chain
12/19/2006	CA2155200C Use of topical anesthetics for the treatment of eosinophil-associated diseases
12/19/2006	CA2149496C 11,21-bisphenyl-19-norpregnane derivatives
12/19/2006	CA2149170C Agent for prevention or alleviation of allergy symptoms
12/19/2006	CA2145064C Improvements in or relating to immune response modification
12/19/2006	CA2098167C Foodstuffs and feedstuffs containing a lipase inhibitor
12/17/2006	CA2549443A1 Diet supplements for causing fast weight loss, improving daytime energy, promoting nighttime relaxation and sleep, controlling appetite and/or increasing metabolism
12/16/2006	CA2512492A1 Methods and reagents for inhibiting cell proliferation
12/14/2006	WO2006133459A1 Indane derivatives as modulators of ion channels
12/14/2006	WO2006133450A2 Anti-cd19 antibody therapy for the transplantation
12/14/2006	WO2006133446A2 Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes
12/14/2006	WO2006133443A2 Regional therapies for treatment of pain
12/14/2006	WO2006133426A2 Compositions and methods for inhibition of the jak pathway
12/14/2006	WO2006133417A1 Phenylamino isothiazole carboxamidines as mek inhibitors
12/14/2006	WO2006133411A1 Methods and compositions for the treatment of ocular disorders
12/14/2006	WO2006133393A1 Treatment of sleep-wake disorders
12/14/2006	WO2006133391A2 Improved treatment for anemia using a hif-alpha stabilising agent
12/14/2006	WO2006133375A2 Dinucleoside polyphosphate inhibitors of reverse transcriptase
12/14/2006	WO2006133374A2 Methods for treating shock

1 ... 3963 3964 3965 3966 3967 3968 3969 3970 3971 3972 3973 3974 3975 3976 3977 3978 3979 3980 3981 3982 3983 ... 7860